Yanmei Gu

661 total citations
19 papers, 223 citations indexed

About

Yanmei Gu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yanmei Gu has authored 19 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yanmei Gu's work include Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Yanmei Gu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Yanmei Gu collaborates with scholars based in China. Yanmei Gu's co-authors include Yumin Li, Fan Zhang, Cong Chen, Ling Wang, Ning Zhou, Yating Zhang, Luxi Yang, Yang Zhao, Futian Tang and Zhengchao Zhang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Small and Gene.

In The Last Decade

Yanmei Gu

16 papers receiving 217 citations

Peers

Yanmei Gu
Mei Xie China
Marco Schupp United States
Ryan Massa United States
Yanmei Gu
Citations per year, relative to Yanmei Gu Yanmei Gu (= 1×) peers Kazuhiro Togasaki

Countries citing papers authored by Yanmei Gu

Since Specialization
Citations

This map shows the geographic impact of Yanmei Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanmei Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanmei Gu more than expected).

Fields of papers citing papers by Yanmei Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanmei Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanmei Gu. The network helps show where Yanmei Gu may publish in the future.

Co-authorship network of co-authors of Yanmei Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanmei Gu. A scholar is included among the top collaborators of Yanmei Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanmei Gu. Yanmei Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Wang, Jianrong, et al.. (2025). P2RX4 promotes hepatocellular carcinoma progression via calcium-mediated PI3K/AKT activation and immune remodeling. World Journal of Surgical Oncology. 23(1). 363–363.
3.
Teng, Muzhou, et al.. (2025). Transforming the Tumor Microenvironment: An Outstanding AIE‐Active Photosensitizer to Boost the Effectiveness of Immunotherapy. Small. 21(26). e2503355–e2503355. 1 indexed citations
4.
Liu, Tiantian, Yanmei Gu, Yuyu Zhang, & Yumin Li. (2024). Integrin α2 in the microenvironment and the tumor compartment of digestive (gastrointestinal) cancers: emerging regulators and therapeutic opportunities. Frontiers in Oncology. 14. 1439709–1439709. 1 indexed citations
5.
Sun, Xiao‐Qing, et al.. (2024). Factors Influencing Stress Disorders in Intensive Care Unit (ICU) Patients After Liver Transplantation: A Cross-Sectional Study. Annals of Transplantation. 29. e944320–e944320. 1 indexed citations
6.
Gu, Yanmei, et al.. (2024). Efficacy of CalliSpheres ® drug-loaded microspheres combined with doxorubicin in hepatocellular carcinoma. Scandinavian Journal of Gastroenterology. 59(9). 1087–1092. 1 indexed citations
7.
Gu, Yanmei, Futian Tang, Bin Zhao, et al.. (2023). STAT1 suppresses the transcriptional activity of TRIM21 in gastric cancer. Journal of Cancer Research and Clinical Oncology. 149(17). 15335–15348. 3 indexed citations
8.
Gu, Yanmei, et al.. (2023). Organoids: Construction and Application in Gastric Cancer. Biomolecules. 13(5). 875–875. 8 indexed citations
9.
Teng, Muzhou, Zhijia Li, Yanmei Gu, et al.. (2023). Real-time monitoring of glucose metabolism and effects of metformin on HepG2 cells using 13C in-cell NMR spectroscopy. Biochemical and Biophysical Research Communications. 694. 149383–149383. 4 indexed citations
11.
Gu, Yanmei, et al.. (2023). Application of enhanced recovery after surgery following liver transplantation. World Journal of Surgical Oncology. 21(1). 248–248. 3 indexed citations
12.
13.
Gu, Yanmei, et al.. (2022). Overcome tumor relapse in CAR T cell therapy. Clinical & Translational Oncology. 24(10). 1833–1843. 3 indexed citations
15.
Chen, Cong, Yanmei Gu, Fan Zhang, et al.. (2021). Construction of PD1/CD28 chimeric-switch receptor enhances anti-tumor ability of c-Met CAR-T in gastric cancer. OncoImmunology. 10(1). 1901434–1901434. 57 indexed citations
16.
Gu, Yanmei, et al.. (2021). Metastasis Pattern and Survival Analysis in Primary Small Bowel Adenocarcinoma: A SEER-Based Study. Frontiers in Surgery. 8. 759162–759162. 7 indexed citations
17.
Chen, Gang, Yumin Li, Zhijian Ren, et al.. (2020). Clinical Significance of MicroRNA-155-Regulated Autophagy and Apoptosis by Targeting Rictor/Fos in Gastric Cancer Progression. Nanoscience and Nanotechnology Letters. 12(4). 525–535. 3 indexed citations
18.
Guo, Lingyun, Zhenjiang Wang, Yuanyuan Du, et al.. (2020). Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma. Cancer Cell International. 20(1). 251–251. 39 indexed citations
19.
Chen, Cong, Fan Zhang, Ning Zhou, et al.. (2019). Efficacy and safety of immune checkpoint inhibitors in advanced gastric or gastroesophageal junction cancer: a systematic review and meta-analysis. OncoImmunology. 8(5). e1581547–e1581547. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026